Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster successfully - treated

Terms

4successfully
19treated
25patient
10pneumonia
10agents
16biological

Associations

Freq.WeightAssociation
40.459successfully - treated
40.253patient - pneumonia
50.229patient - treated
40.316agents - biological
30.172biological - treated
Documents par ordre de pertinence
000209 (2020) Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.
000029 (2020) Sara Benchérifa ; Bouchra Amine ; Imane El Binoune ; Samira Rostom ; Rachid BahiriTwo cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy
000330 (2020) Cécile Dumaine [France] ; Sara Bekkar [France] ; Alexandre Belot [France] ; Natalia Cabrera [France] ; Salma Malik [France] ; Annette Von Scheven [Suisse] ; Aurelia Carbasse [France] ; Andreas Woerner [Suisse] ; Carine Wouters [Belgique] ; Kenza Bouayed ; Pascal Pillet [France] ; Silke Schroeder [Suisse] ; Michael Hofer [Suisse] ; Véronique Hentgen [France]Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
000381 (2020) Xuhan Zhang [République populaire de Chine] ; Kaidi Song [République populaire de Chine] ; Fei Tong [République populaire de Chine] ; Mingming Fei [République populaire de Chine] ; Hui Guo [République populaire de Chine] ; Zhaohui Lu [République populaire de Chine] ; Jinquan Wang [République populaire de Chine] ; Changcheng Zheng [République populaire de Chine]First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
000456 (2020) Francesco Fontana [Italie] ; Gaetano Alfano [Italie] ; Giacomo Mori [Italie] ; Alessio Amurri [Italie] ; Tei Lorenzo [Italie] ; Marco Ballestri [Italie] ; Marco Leonelli [Italie] ; Francesca Facchini [Italie] ; Francesca Damiano [Italie] ; Riccardo Magistroni [Italie] ; Gianni Cappelli [Italie]Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.
000031 (2020) Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France]Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab.
000037 (2020) Huiqiong Zeng ; Baiwei Luo ; Yue Zhang ; Zhongyu Xie ; Zhizhong YeTreatment of reactive arthritis with biological agents: a review
000109 (2020) Eric Toussirot [France]The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000384 (2020) M. Cellina [Italie] ; M. Orsi [Italie] ; F. Bombaci [Italie] ; M. Sala [Italie] ; P. Marino [Italie] ; G. Oliva [Italie]Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.
000442 (2020) Joanna Makowska ; Anna Lewandowska-PolakDesensitization to biological agents used in rheumatology
000469 (2020) Jehun Song [Corée du Sud] ; Seongmin Kang [Corée du Sud] ; Seung Won Choi [Corée du Sud] ; Kwang Won Seo [Corée du Sud] ; Sunggun Lee [Corée du Sud] ; Min Wook So [Corée du Sud] ; Doo-Ho Lim [Corée du Sud]Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
000544 (2020) Carina Mihai [Suisse] ; Rucsandra Dobrota [Suisse] ; Maria Schröder [Suisse] ; Alexandru Garaiman [Suisse] ; Suzana Jordan [Suisse] ; Mike Oliver Becker [Suisse] ; Britta Maurer [Suisse] ; Oliver Distler [Suisse]COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
000545 (2020) Giovanni Novi [Italie] ; Malgorzata Mikulska [Italie] ; Federica Briano [Italie] ; Federica Toscanini [Italie] ; Francesco Tazza [Italie] ; Antonio Uccelli [Italie] ; Matilde Inglese [Italie]COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
000594 (2020) Elena Giacomelli ; Walter Dorigo ; Aaron Fargion ; Gianmarco Calugi ; Giovanni Cianchi ; Carlo PratesiAcute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia
000023 (2020) Yehyun Park [Corée du Sud] ; Jae Hee Cheon [Corée du Sud]Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
000038 (2020) Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000040 (2020) S. Panopoulos [Grèce] ; Chatzidionysiou [Grèce] ; M. G. Tektonidou [Grèce] ; V. K. Bournia [Grèce] ; A. A. Drosos [Grèce] ; Stamatis-Nick C. Liossis [Grèce] ; T. Dimitroulas [Grèce] ; L. Sakkas [Grèce] ; D. Boumpas [Grèce] ; P. V. Voulgari [Grèce] ; D. Daoussis [Grèce] ; K. Thomas [Grèce] ; G. Georgiopoulos [Grèce] ; G. Vosvotekas [Grèce] ; Garyfallos [Grèce] ; P. Sidiropoulos [Grèce] ; G. Bertsias [Grèce] ; D. Vassilopoulos [Grèce] ; P. P. Sfikakis [Grèce]Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort
000065 (2020) Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse]Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
000082 (2020) Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000126 (2020) E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne]T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
000141 (2020) Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000150 (2020) Giovanna Garufi [Italie] ; Luisa Carbognin [Italie] ; Armando Orlandi [Italie] ; Giampaolo Tortora [Italie] ; Emilio Bria [Italie]Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence.
000155 (2020) Meng Xu ; Congcong Liu ; Lishuang Guo ; Sirui YangSevere sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report
000156 (2020) Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000157 (2020) Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000162 (2020) Alexandre Sepriano [Oman] ; Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas]Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
000163 (2020) Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000205 (2020) Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis]Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
000207 (2020) Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang QiRational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
000212 (2020) Nanase Honda [Japon] ; Naoto Yokogawa [Japon] ; Tomohiro Koga ; Yushiro Endo ; Shiro Matsubara [Japon]Protracted Febrile Myalgia Syndrome Treated With Tocilizumab.
000221 (2020) Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000223 (2020) Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih ChangPotential therapeutic agents against COVID-19: What we know so far
000242 (2020) Colin H. Holtze [États-Unis] ; Elizabeth A. Freiheit [États-Unis] ; Susan L. Limb [États-Unis] ; John L. Stauffer [États-Unis] ; Karina Raimundo [États-Unis] ; Wayne T. Pan [États-Unis] ; Kevin R. Flaherty [États-Unis] ; Hyun J. Kim [États-Unis]Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
000245 (2020) Ana Luisa Oliveira [Portugal] ; Carina Ruano [Portugal] ; Nuno Riso [Portugal] ; José Cepeda Ribeiro [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia.
000261 (2020) R. Tonelli [Italie] ; A. Iattoni [Italie] ; M. Girardis [Italie] ; L. De Pietri [Italie] ; E. Clini [Italie] ; C. Mussini [Italie]Never Give Up: Lesson learned from a severe COVID-19 patient
000287 (2020) Tania Jain ; Mark R. LitzowManagement of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia
000295 (2020) Charles Peterfy [États-Unis] ; Joel Kremer [États-Unis] ; William Rigby [États-Unis] ; Nora Singer [États-Unis] ; Christine Birchwood [États-Unis] ; Darcy Gill [États-Unis] ; William Reiss [États-Unis] ; Jinglan Pei [États-Unis] ; Margaret Michalska [États-Unis]Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy.
000308 (2020) Clemens Oerding [Allemagne] ; Ingmar Kaden [Allemagne] ; Kai Wohlfarth [Allemagne]Isolated Bilateral Internal Carotid Artery Stenosis and Recurrent Ischemic Strokes in a Patient with Suspected Giant Cell Arteritis
000311 (2020) Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde]Is biological therapy in systemic sclerosis the answer?
000316 (2020) Yuki Saito [Japon] ; Shujiro Hayashi [Japon] ; Takashi Gonmori [Japon] ; Yoichiro Hamasaki [Japon] ; Ken Igawa [Japon]Interrupting tocilizumab therapy-induced psoriasis-like eruption in a patient with rheumatoid arthritis and Crohn's disease.
000338 (2020) Ivan Arias De La Rosa [Espagne] ; Carlos Perez-Sanchez [Royaume-Uni] ; Patricia Ruiz-Limon [Espagne] ; Alejandra Pati O-Trives [Espagne] ; Carmen Torres-Granados [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Irene Cecchi [Italie] ; Rafaela Ortega [Espagne] ; Miguel Angel Caracuel [Espagne] ; Jerusalem Calvo-Gutierrez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Chary Lopez-Pedrera [Espagne] ; Nuria Barbarroja [Oman]Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.
000365 (2020) Richard T. Maziarz [États-Unis] ; Stephen J. Schuster [États-Unis] ; Vadim V. Romanov [États-Unis] ; Elisha S. Rusch [États-Unis] ; Junlong Li [États-Unis] ; James E. Signorovitch [États-Unis] ; David G. Maloney [États-Unis] ; Frederick L. Locke [États-Unis]Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial
000366 (2020) Stephen J. Schuster [États-Unis] ; Richard T. Maziarz [États-Unis] ; Elisha S. Rusch [États-Unis] ; Junlong Li [États-Unis] ; James E. Signorovitch [États-Unis] ; Vadim V. Romanov [États-Unis] ; Frederick L. Locke [États-Unis] ; David G. Maloney [États-Unis]Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial
000390 (2020) Patricia Richi [Espagne] ; Oriol Alonso [Espagne] ; María Dolores Martín [Espagne] ; Laura González-Hombrado [Espagne] ; Teresa Navío [Espagne] ; Marina Salido [Espagne] ; Jesús Llorente [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Cristina García-Fernández [Espagne] ; Ana Jiménez-Diaz [Espagne] ; Leticia Lojo [Espagne] ; Laura Cebrián [Espagne] ; Israel Thuissard-Vasallo [Espagne] ; María José Martínez De Aramayona [Espagne] ; Tatiana Cobo [Espagne] ; Marta García-Castro [Espagne] ; Patricia Castro [Espagne] ; M Nica Fernández-Castro [Espagne] ; Scar Illera [Espagne] ; Martina Steiner [Espagne] ; Santiago Mu Oz-Fernández [Espagne]Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study.
000412 (2020) Sathana Ingaralingam [Royaume-Uni] ; Saaeha Rauz [Royaume-Uni] ; Philip I. Murray [Royaume-Uni] ; Robert J. Barry [Royaume-Uni]Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol
000420 (2020) Chihiro Iwao [Japon] ; Kunihiko Umekita [Japon] ; Shunichi Miyauchi [Japon] ; Masatoshi Kimura [Japon] ; Yuki Rikitake [Japon] ; Koushou Iwao [Japon] ; Mao Rikitake [Japon] ; Ayako Aizawa [Japon] ; Takeshi Kawaguchi [Japon] ; Yumi Kariya [Japon] ; Motohiro Matsuda [Japon] ; Ichiro Takajo [Japon] ; Kazutaka Shiomi [Japon] ; Akihiko Okayama [Japon]Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
000424 (2020) Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis]Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France.
000429 (2020) Josef S. Smolen [Autriche] ; Robert B M. Landewé [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Andreas Kerschbaumer [Autriche] ; Iain B. Mcinnes [Royaume-Uni] ; Alexandre Sepriano [Pays-Bas] ; Ronald F. Van Vollenhoven [Pays-Bas] ; Maarten De Wit [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; John Askling [Suède] ; Alejandro Balsa [Espagne] ; Maarten Boers [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Maya H. Buch [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Roberto Caporali [Italie] ; Mario Humberto Cardiel [Mexique] ; Diederik De Cock [Belgique] ; Catalin Codreanu [Roumanie] ; Maurizio Cutolo [Italie] ; Christopher John Edwards [Royaume-Uni] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Royaume-Uni] ; Axel Finckh [Suisse] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Merete Lund Hetland [Danemark] ; Tom W J. Huizinga [Pays-Bas] ; Marios Koloumas [Suisse] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Ulf Müller-Ladner [Allemagne] ; Eduardo F. Mysler [Argentine] ; Jose A P. Da Silva [Portugal] ; Gyula Po R [Hongrie] ; Janet E. Pope [Canada] ; Andrea Rubbert-Roth [Suisse] ; Adeline Ruyssen-Witrand [France] ; Kenneth G. Saag [États-Unis] ; Anja Strangfeld [Allemagne] ; Tsutomu Takeuchi [Japon] ; Marieke Voshaar [Pays-Bas] ; René Westhovens [Belgique] ; Désirée Van Der Heijde [Pays-Bas]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
000437 (2020) Catalina Sanchez-Alvarez [États-Unis] ; Matthew Koster [États-Unis] ; Ali Duarte-García [États-Unis] ; Kenneth J. Warrington [États-Unis]Disease progression of Takayasu arteritis in two patients treated with tocilizumab.
000439 (2020) L. Baganz [Allemagne] ; J. Listing [Allemagne] ; J. Kekow [Allemagne] ; C. Eisterhues [Allemagne] ; S. Wassenberg [Allemagne] ; A. Zink [Allemagne] ; A. Strangfeld [Allemagne]Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis.
000459 (2020) Benjamin Birkner [Allemagne] ; Jürgen Rech [Allemagne] ; Tom Stargardt [Allemagne]Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
000486 (2020) Rishi J. Desai ; Sara Dejene ; Yinzhu Jin ; Jun Liu ; Seoyoung C. KimComparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Drugs: A Cohort Study
000493 (2020) Alessandro Allegra ; Caterina Musolino ; Alessandro Tonacci ; Giovanni Pioggia ; Marco Casciaro ; Sebastiano GangemiClinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
000494 (2020) Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000541 (2020) Cindy B. Yeoh ; Kathleen J. Lee ; Elizabeth F. Rieth ; Renee Mapes ; Anna V. Tchoudovskaia ; Gregory W. Fischer ; Luis E. TollincheCOVID-19 in the Cancer Patient
000581 (2020) Atsushi Noguchi [Japon] ; Shinsuke Yasuda [Japon] ; Ryo Hisada [Japon] ; Masaru Kato [Japon] ; Kenji Oku [Japon] ; Toshiyuki Bohgaki [Japon] ; Miho Suzuki [Japon] ; Yoshihiro Matsumoto [Japon] ; Tatsuya Atsumi [Japon]Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.
000602 (2020) Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Nicole Zambetti [Italie] ; Marianna Moscato [Italie] ; Margherita Venturini [Italie] ; Stefania Affatato [Italie] ; Mario Gaggiotti [Italie] ; Nicola Bossini [Italie] ; Francesco Scolari [Italie]A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
000606 (2020) Xiao-Shan Wei [République populaire de Chine] ; Xiao-Rong Wang [République populaire de Chine] ; Jian-Chu Zhang [République populaire de Chine] ; Wei-Bing Yang [République populaire de Chine] ; Wan-Li Ma [République populaire de Chine] ; Bo-Han Yang [République populaire de Chine] ; Nan-Chuan Jiang [République populaire de Chine] ; Zhan-Cheng Gao [République populaire de Chine] ; Huan-Zhong Shi [République populaire de Chine] ; Qiong Zhou [République populaire de Chine]A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2
000610 (2020) Antoney J. Ferrey [États-Unis] ; Grace Choi [États-Unis] ; Ramy M. Hanna [États-Unis] ; Yongen Chang [États-Unis] ; Ekamol Tantisattamo [États-Unis] ; Kaushik Ivaturi [États-Unis] ; Elisa Park [États-Unis] ; Lawrence Nguyen [États-Unis] ; Brian Wang [États-Unis] ; Sam Tonthat [États-Unis] ; Connie M. Rhee [États-Unis] ; Uttam Reddy [États-Unis] ; Wei Ling Lau [États-Unis] ; Susan S. Huang [États-Unis] ; Shruti Gohil [États-Unis] ; Alpesh N. Amin [États-Unis] ; Lanny Hsieh [États-Unis] ; Timmy T. Cheng [États-Unis] ; Richard A. Lee [États-Unis] ; Kamyar Kalantar-Zadeh [États-Unis]A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease
000618 (2019) Maurizio Benucci [Italie] ; Valentina Grossi [Italie] ; Mariangela Manfredi [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Paolo Moscato [Italie] ; Luigi Cinquanta [Italie] ; Elisa Gremese [Italie] ; Barbara Tolusso [Italie] ; Luca Petricca [Italie] ; Anna Laura Fedele [Italie] ; Stefano Alivernini [Italie] ; Fabiola Atzeni [Italie] ; Giovanni Minisola [Italie] ; Roberto Verna [Italie]Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
000633 (????) Ryan W. Stevens ; Lynn Estes ; Christina RiveraPractical implementation of COVID-19 patient flags into an antimicrobial stewardship program’s prospective review
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021